Please Wait.....
Report
Europe Prosthetic Heart Valve Market By Product (Tissue Heart Valve, Mechanical Heart Valve, Transcatheter Heart Valve) , : Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-10-01 I 110 Pages I Allied Market Research
Europe Prosthetic Heart Valve Market
The Europe prosthetic heart valve market was valued at $2.5 billion in 2023 and is projected to reach $7.1 billion by 2033, growing at a CAGR of 11.1% from 2024 to 2033.
A prosthetic heart valve is an artificial device that replaces the damaged native valves of the human heart. Its functioning remains similar to the natural valves, which open and close during every heartbeat to facilitate efficient flow of blood into the whole body. Prosthetic valves are either bioprosthetic that are made from natural tissues extracted from animals or humans. Or they are mechanical, which are created using robust materials such as titanium or carbon. The durability of these devices ensures their functioning for 20-30 years and reduces the possibility of blood clotting near the surface.
The exponentially increasing geriatric population in Europe is expected to increase the number of cases of cardiovascular disorders in the coming years. This is poised to fuel the need for prosthetic heart valves and propel the growth of the market. In addition, rapid adoption of technological advancements in the healthcare industry is a key driver of the Europe prosthetic heart valve market. For instance, the advent of minimally invasive surgical procedures such as transcatheter-based implantation has led to short recovery times and improved clinical outcomes. To enhance the efficacy of the device, the trend of integrating wireless smart sensors into the valves is gaining prominence. These sensors monitor the pressure gradient and blood flow through the heart in real time, enabling early detection of issues post-surgery.
However, concerns pertaining to the risks associated with the implantation of prosthetic heart valves hamper the development of the market. According to Medindia-an Indian health website-mechanical heart valves have a high possibility of thrombotic and thromboembolic complications, resulting in their failure in 10-15% of the implantation cases. Furthermore, around 3-9% of the surgeries exhibit the risk of death of patients. On the contrary, ongoing research studies to develop biomimetic prosthetic valves are expected to reduce the associated risks and present lucrative opportunities for the market expansion. These types of valves are a combination of synthetic and natural materials that possess enhanced durability and reduced risk of mechanical wear. Therefore, the development of ingenious, long-lasting valves is poised to open new avenues for the Europe prosthetic heart valve market.
Segment Review
The Europe prosthetic heart valve market is segmented into product and region. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve. Country wise, it is analyzed across Germany, France, the UK, Italy, Spain, and Rest of Europe.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the Europe prosthetic heart valve market include Bracco, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott Laboratories, Artivion, Inc., Meril Life Sciences Pvt. Ltd., ShockWave Medical, Inc., Novostia SA, and JenaValve Technology, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Tissue Heart Valve
- Stented Tissue Heart Valve
- Stentless Tissue Heart Valve
- Mechanical Heart Valve
- Transcatheter Heart Valve
By Country
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Key Market Players
- Bracco
- Edwards Lifesciences Corporation
- Medtronic
- Boston Scientific Corporation
- Abbott Laboratories
- Artivion, Inc
- Meril Life Sciences Pvt. Ltd.
- ShockWave Medical, Inc.
- Novostia SA
- JenaValve Technology, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Share Analysis, By Country
4.2.3. Stented Tissue Heart Valve
4.2.4. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Share Analysis, By Country
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Share Analysis, By Country
CHAPTER 5: EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Country
5.2. Europe
5.2.2. Key Market Trends and Opportunities
5.2.2. Market Size and Forecast, By Product
5.2.3. Market Size and Forecast, By Country
5.2.4.Germany
5.2.4.1. Market Size and Forecast, By Product
5.2.5.France
5.2.5.1. Market Size and Forecast, By Product
5.2.6.UK
5.2.6.1. Market Size and Forecast, By Product
5.2.7.Italy
5.2.7.1. Market Size and Forecast, By Product
5.2.8.Spain
5.2.8.1. Market Size and Forecast, By Product
5.2.9.Rest Of Europe
5.2.9.1. Market Size and Forecast, By Product
CHAPTER 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.2. Top Winning Strategies
6.3. Product Mapping Of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Top Player Positioning,2023
CHAPTER 7: COMPANY PROFILES
7.1. Bracco
7.1.1. Company Overview
7.1.2. Key Executives
7.1.3. Company Snapshot
7.1.4. Operating Business Segments
7.1.5. Product Portfolio
7.1.6. Business Performance
7.1.7. Key Strategic Moves and Developments
7.2. Edwards Lifesciences Corporation
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Operating Business Segments
7.2.5. Product Portfolio
7.2.6. Business Performance
7.2.7. Key Strategic Moves and Developments
7.3. Medtronic
7.3.1. Company Overview
7.3.2. Key Executives
7.3.3. Company Snapshot
7.3.4. Operating Business Segments
7.3.5. Product Portfolio
7.3.6. Business Performance
7.3.7. Key Strategic Moves and Developments
7.4. Boston Scientific Corporation
7.4.1. Company Overview
7.4.2. Key Executives
7.4.3. Company Snapshot
7.4.4. Operating Business Segments
7.4.5. Product Portfolio
7.4.6. Business Performance
7.4.7. Key Strategic Moves and Developments
7.5. Abbott Laboratories
7.5.1. Company Overview
7.5.2. Key Executives
7.5.3. Company Snapshot
7.5.4. Operating Business Segments
7.5.5. Product Portfolio
7.5.6. Business Performance
7.5.7. Key Strategic Moves and Developments
7.6. Artivion, Inc
7.6.1. Company Overview
7.6.2. Key Executives
7.6.3. Company Snapshot
7.6.4. Operating Business Segments
7.6.5. Product Portfolio
7.6.6. Business Performance
7.6.7. Key Strategic Moves and Developments
7.7. Meril Life Sciences Pvt. Ltd.
7.7.1. Company Overview
7.7.2. Key Executives
7.7.3. Company Snapshot
7.7.4. Operating Business Segments
7.7.5. Product Portfolio
7.7.6. Business Performance
7.7.7. Key Strategic Moves and Developments
7.8. ShockWave Medical, Inc.
7.8.1. Company Overview
7.8.2. Key Executives
7.8.3. Company Snapshot
7.8.4. Operating Business Segments
7.8.5. Product Portfolio
7.8.6. Business Performance
7.8.7. Key Strategic Moves and Developments
7.9. Novostia SA
7.9.1. Company Overview
7.9.2. Key Executives
7.9.3. Company Snapshot
7.9.4. Operating Business Segments
7.9.5. Product Portfolio
7.9.6. Business Performance
7.9.7. Key Strategic Moves and Developments
7.10. JenaValve Technology, Inc.
7.10.1. Company Overview
7.10.2. Key Executives
7.10.3. Company Snapshot
7.10.4. Operating Business Segments
7.10.5. Product Portfolio
7.10.6. Business Performance
7.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 3. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 4. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 5. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 6. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 7. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 8. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 9. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 10. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 11. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 12. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 13. BRACCO: KEY EXECUTIVES
TABLE 14. BRACCO: COMPANY SNAPSHOT
TABLE 15. BRACCO: OPERATING SEGMENTS
TABLE 16. BRACCO: PRODUCT PORTFOLIO
TABLE 17. BRACCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 18. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 19. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 20. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 21. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 22. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 23. MEDTRONIC: KEY EXECUTIVES
TABLE 24. MEDTRONIC: COMPANY SNAPSHOT
TABLE 25. MEDTRONIC: OPERATING SEGMENTS
TABLE 26. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 27. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 28. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 29. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 30. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 31. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 33. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 34. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 35. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 36. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 37. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 38. ARTIVION, INC: KEY EXECUTIVES
TABLE 39. ARTIVION, INC: COMPANY SNAPSHOT
TABLE 40. ARTIVION, INC: OPERATING SEGMENTS
TABLE 41. ARTIVION, INC: PRODUCT PORTFOLIO
TABLE 42. ARTIVION, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 44. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 45. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 46. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 47. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
TABLE 49. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 50. SHOCKWAVE MEDICAL, INC.: OPERATING SEGMENTS
TABLE 51. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 52. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. NOVOSTIA SA: KEY EXECUTIVES
TABLE 54. NOVOSTIA SA: COMPANY SNAPSHOT
TABLE 55. NOVOSTIA SA: OPERATING SEGMENTS
TABLE 56. NOVOSTIA SA: PRODUCT PORTFOLIO
TABLE 57. NOVOSTIA SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 59. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 60. JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS
TABLE 61. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 62. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 10. EUROPE PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 20. TOP PLAYER POSITIONING,2023
FIGURE 21. BRACCO: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. BRACCO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. BRACCO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ARTIVION, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ARTIVION, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ARTIVION, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SHOCKWAVE MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. NOVOSTIA SA: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. NOVOSTIA SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. NOVOSTIA SA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. JENAVALVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
LIST OF TABLES
TABLE 1. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 3. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 4. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 5. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 6. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 7. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 8. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 9. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 10. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 11. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 12. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 13. BRACCO: KEY EXECUTIVES
TABLE 14. BRACCO: COMPANY SNAPSHOT
TABLE 15. BRACCO: OPERATING SEGMENTS
TABLE 16. BRACCO: PRODUCT PORTFOLIO
TABLE 17. BRACCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 18. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 19. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 20. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 21. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 22. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 23. MEDTRONIC: KEY EXECUTIVES
TABLE 24. MEDTRONIC: COMPANY SNAPSHOT
TABLE 25. MEDTRONIC: OPERATING SEGMENTS
TABLE 26. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 27. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 28. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 29. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 30. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 31. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 33. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 34. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 35. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 36. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 37. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 38. ARTIVION, INC: KEY EXECUTIVES
TABLE 39. ARTIVION, INC: COMPANY SNAPSHOT
TABLE 40. ARTIVION, INC: OPERATING SEGMENTS
TABLE 41. ARTIVION, INC: PRODUCT PORTFOLIO
TABLE 42. ARTIVION, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 44. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 45. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 46. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 47. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
TABLE 49. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 50. SHOCKWAVE MEDICAL, INC.: OPERATING SEGMENTS
TABLE 51. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 52. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. NOVOSTIA SA: KEY EXECUTIVES
TABLE 54. NOVOSTIA SA: COMPANY SNAPSHOT
TABLE 55. NOVOSTIA SA: OPERATING SEGMENTS
TABLE 56. NOVOSTIA SA: PRODUCT PORTFOLIO
TABLE 57. NOVOSTIA SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 59. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 60. JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS
TABLE 61. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 62. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 10. EUROPE PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 20. TOP PLAYER POSITIONING,2023
FIGURE 21. BRACCO: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. BRACCO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. BRACCO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ARTIVION, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ARTIVION, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ARTIVION, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SHOCKWAVE MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. NOVOSTIA SA: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. NOVOSTIA SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. NOVOSTIA SA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. JENAVALVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security